# Yestoday

翻译：

- [衡量护城河：评估价值创造的规模和可持续性](https://github.com/pzponge/Yestoday/blob/main/Translation/%E8%A1%A1%E9%87%8F%E6%8A%A4%E5%9F%8E%E6%B2%B3%EF%BC%9A%E8%AF%84%E4%BC%B0%E4%BB%B7%E5%80%BC%E5%88%9B%E9%80%A0%E7%9A%84%E8%A7%84%E6%A8%A1%E5%92%8C%E5%8F%AF%E6%8C%81%E7%BB%AD%E6%80%A7.md)
- [ROIC 的重要性（第一部分）：累进增长型企业（Compounder）和廉价股票](https://github.com/pzponge/Yestoday/blob/main/Translation/ROIC%20%E7%9A%84%E9%87%8D%E8%A6%81%E6%80%A7%EF%BC%88%E7%AC%AC%E4%B8%80%E9%83%A8%E5%88%86%EF%BC%89%EF%BC%9A%E7%B4%AF%E8%BF%9B%E5%A2%9E%E9%95%BF%E5%9E%8B%E4%BC%81%E4%B8%9A%EF%BC%88Compounder%EF%BC%89%E5%92%8C%E5%BB%89%E4%BB%B7%E8%82%A1%E7%A5%A8.md)
- [ROIC 的重要性（第二部分）：累进增长型企业（Compounder）和廉价股票](https://github.com/pzponge/Yestoday/blob/main/Translation/ROIC%20%E7%9A%84%E9%87%8D%E8%A6%81%E6%80%A7%EF%BC%88%E7%AC%AC%E4%BA%8C%E9%83%A8%E5%88%86%EF%BC%89%EF%BC%9A%E7%B4%AF%E8%BF%9B%E5%A2%9E%E9%95%BF%E5%9E%8B%E4%BC%81%E4%B8%9A%EF%BC%88Compounder%EF%BC%89%E5%92%8C%E5%BB%89%E4%BB%B7%E8%82%A1%E7%A5%A8.md)
- [ROIC 的重要性（第三部分）：复利和再投资](https://github.com/pzponge/Yestoday/blob/main/Translation/ROIC%20%E7%9A%84%E9%87%8D%E8%A6%81%E6%80%A7%EF%BC%88%E7%AC%AC%E4%B8%89%E9%83%A8%E5%88%86%EF%BC%89%EF%BC%9A%E5%A4%8D%E5%88%A9%E5%92%8C%E5%86%8D%E6%8A%95%E8%B5%84.md)
- [ROIC 的重要性（第四部分）：复利的数学原理](https://github.com/pzponge/Yestoday/blob/main/Translation/ROIC%20%E7%9A%84%E9%87%8D%E8%A6%81%E6%80%A7%EF%BC%88%E7%AC%AC%E5%9B%9B%E9%83%A8%E5%88%86%EF%BC%89%EF%BC%9A%E5%A4%8D%E5%88%A9%E7%9A%84%E6%95%B0%E5%AD%A6%E5%8E%9F%E7%90%86.md)
- [ROIC 的重要性（第五部分）：富国银行过去 42 年历史一瞥](https://github.com/pzponge/Yestoday/blob/main/Translation/ROIC%20%E7%9A%84%E9%87%8D%E8%A6%81%E6%80%A7%EF%BC%88%E7%AC%AC%E4%BA%94%E9%83%A8%E5%88%86%EF%BC%89%EF%BC%9A%E5%AF%8C%E5%9B%BD%E9%93%B6%E8%A1%8C%E8%BF%87%E5%8E%BB%2042%20%E5%B9%B4%E5%8E%86%E5%8F%B2%E4%B8%80%E7%9E%A5.md)
- [ROIC 的重要性：再投资护城河与传统护城河](https://github.com/pzponge/Yestoday/blob/main/Translation/ROIC%20%E7%9A%84%E9%87%8D%E8%A6%81%E6%80%A7%EF%BC%9A%E5%86%8D%E6%8A%95%E8%B5%84%E6%8A%A4%E5%9F%8E%E6%B2%B3%E4%B8%8E%E4%BC%A0%E7%BB%9F%E6%8A%A4%E5%9F%8E%E6%B2%B3.md)
